Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population

Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program

Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199 · see citing works

Cancer regression and autoimmunity induced by cytotoxic t lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575 · see citing works

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830997100 · Cited by 1,006 · see citing works

CTLA-4: new insights into its biological function and use in tumor immunotherapy

Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940 · see citing works

Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934 · see citing works

A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION

Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090535 · Cited by 518 · see citing works

CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction

Contardi, E., Palmisano, G. L., Tazzari, P. L., Martelli, A. M., Falà, F., Fabbi, M., Kato, T., Lucarelli, E., Donati, D. M., Polito, L., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21155 · Cited by 324 · see citing works

Modification of enzymatic-ally amplified DNA for the detection of point mutations

Haliassos, A., Chomel, J., Tesson, L., Baudis, M., Kruh, J., Jc, K., & Kitzis, A. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.9.3606 · Cited by 316 · see citing works

Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.

Wittig, J. C., Bickels, J., Priebat, D. A., Jelinek, J. S., Kellar-Graney, K., Shmookler, B. M., & Malawer, M. M. (2002) · PubMed · Cited by 299 · see citing works

Endocrine gland cancer

Correct, P., & Chen, V. W. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1+ · Cited by 154 · see citing works

Biology of Osteogenic Sarcoma

Wang, L. L. (2005) · The Cancer Journal · doi:10.1097/00130404-200507000-00005 · Cited by 126 · see citing works

Bone cancers

Tideman, H. (1995) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0901-5027(05)80498-9 · Cited by 122 · see citing works

Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle

Yuan, Z., Li, J., Li, J., Gao, X., Gao, H., & Xu, S. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2251-2 · Cited by 101 · see citing works

Primary malignant bone tumors—recent developments

Hameed, M., & Dorfman, H. D. (2011) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2011.02.002 · Cited by 100 · see citing works

Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study

Caronia, D., Patiño‐García, A., Pérez‐Martínez, A., Pita, G., Moreno, L. T., Zalacaín, M., Molina, B., Colmenero, I., Sierrasesúmaga, L., Benitez, J. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026091 · Cited by 90 · see citing works

Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle

Yuan, Z., Li, J., Li, J., Zhang, L., Gao, X., Gao, H. J., & Xu, S. (2012) · Gene · doi:10.1016/j.gene.2012.05.010 · Cited by 81 · see citing works

Analysis of Genes Critical for Growth Regulation Identifies Insulin-like Growth Factor 2 Receptor Variations with Possible Functional Significance as Risk Factors for Osteosarcoma

Savage, S. A., Woodson, K. G., Walk, E. L., Modi, W. S., Liao, J. S., Douglass, C. W., Hoover, R. N., Chanock, S. J., & The National Osteosarcoma Etiology Study Group (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0214 · Cited by 80 · see citing works

SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene

Yuan, Z., Li, J., Li, J., Gao, X., & Shang-zhong, X. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1934-z · Cited by 80 · see citing works

Cytotoxic T-lymphocyte Antigen-4 Polymorphisms and Susceptibility to Osteosarcoma

Liu, Y., He, Z., Feng, D., Shi, G., Gao, R., Wu, X., Song, W., & Yuan, W. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1269 · Cited by 61 · see citing works

Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma

KAWANO, M., ITONAGA, I., IWASAKI, T., & TSUMURA, H. (2013) · Oncology Reports · doi:10.3892/or.2013.2224 · Cited by 51 · see citing works

[The establishment of method for identifying SNP genotype by CRS-PCR].

Zhao, C., Li, N., & Deng, X. (2003) · PubMed · Cited by 50 · see citing works

CD40 C/T-1 and CTLA-4 A/G49 SNPs are associated with autoimmune thyroid diseases in the Chinese population

Yang, J., Qin, Q., Yan, N., Zhu, Y., Cui, L., Yang, X.-J., Wang, X., Pandey, M. S., Hou, P., & Zhang, J. (2011) · Endocrine · doi:10.1007/s12020-011-9510-1 · Cited by 50 · see citing works

Glutathione S-transferase polymorphisms in osteosarcoma patients

Salinas-Souza, C., Petrilli, A. S., & de Toledo, S. R. C. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833caa45 · Cited by 45 · see citing works

Identification of twenty-two candidate markers for human osteogenic sarcoma

Fuchs, B., Zhang, K., Schabel, A., Bolander, M. E., & Sarkar, G. (2001) · Gene · doi:10.1016/s0378-1119(01)00731-4 · Cited by 41 · see citing works

Cytotoxic T-Lymphocyte Antigen-4 +49G/A Polymorphism Is Associated with Increased Risk of Osteosarcoma

Wang, W., Wang, J., Song, H., Liu, J., Song, B., & Cao, X. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0264 · Cited by 39 · see citing works

Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto’s thyroiditis susceptibility: a meta-analysis

Qiu, H., Tang, W., Yin, P., Cheng, F., & Wang, L. (2013) · Endocrine · doi:10.1007/s12020-013-9985-z · Cited by 21 · see citing works

Intrinsic and extrinsic manipulation of B7/CTLA-4 interaction for induction of anti-tumor immunity against osteosarcoma cells.

Nagamori, M., Kawaguchi, S., Murakami, M., Wada, T., Nagoya, S., Yamashita, T., Inobe, M., & Uede, T. (2002) · PubMed · Cited by 14 · see citing works

Association of Hashimoto’s thyroiditis with cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and inducible co-stimulator (ICOS) genes in a Kuwaiti population

AlFadhli, S. M., AlMutawa, Q., Abbas, J. M. K., & Doi, S. A. R. (2012) · Endocrine · doi:10.1007/s12020-012-9823-8 · Cited by 11 · see citing works

The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto’s thyroiditis in Asian but not Caucasian populations: an updated meta-analysis

Feng, M., Zhang, F., & Deng, H. (2013) · Endocrine · doi:10.1007/s12020-013-0014-z · Cited by 10 · see citing works

Translational biology of osteosarcoma

Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294 · see citing works

Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs

Chen, C., Xie, L., Ren, T., Huang, Y., Xu, J. H., & Guo, W. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.024 · Cited by 573 · see citing works

Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy

Gianferante, D. M., Mirabello, L. J., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 470 · see citing works

Advances on immunotherapy for osteosarcoma

Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270 · see citing works

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

Tian, H., Cao, J., Li, B., Nice, E. C., Mao, H., Zhang, Y., & Huang, C. (2023) · Bone Research · doi:10.1038/s41413-023-00246-z · Cited by 239 · see citing works

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities

Wang, Z., Li, B., Ren, Y., & Ye, Z. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00353 · Cited by 73 · see citing works

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality

Yu, L., Zhang, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.871076 · Cited by 68 · see citing works

Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma

Meftahpour, V., Aghebati‐Maleki, A., Fotouhi, A., Safarzadeh, E., & Maleki, L. A. (2021) · EXCLI journal · doi:10.17179/excli2021-4094 · Cited by 27 · see citing works

Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma.

Tie, Z., Bai, R., Zhai, Z., Zhang, G., Zhang, H., Zhao, Z., Zhou, D., & Liu, W. (2014) · Europe PMC (PubMed Central) · Cited by 25 · see citing works

Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.

Sun, Y., Wu, Y., Li, W., Kong, Z., & Zou, X. (2015) · PubMed Central · Cited by 22 · see citing works

Up-regulation of microRNA-496 suppresses proliferation, invasion, migration and in vivo tumorigenicity of human osteosarcoma cells by targeting eIF4E

Qi, N.-N., Tian, S., Li, X., Wang, F., & Liu, B. (2019) · Biochimie · doi:10.1016/j.biochi.2019.04.017 · Cited by 19 · see citing works

Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights

Zhang, Y., Jiang, S., Lv, J., Feng, W., Yu, Y., & Zhao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584450 · Cited by 22 · see citing works

Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance

Asnafi, A. A., Behzad, M. M., Ghanavat, M., Shahjahani, M., & Saki, N. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.12.002 · Cited by 17 · see citing works

Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis

Benna, C., Simioni, A., Pasquali, S., Boni, D. D., Rajendran, S., Spiro, G., Colombo, C., Virgone, C., DuBois, S. G., Gronchi, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24719 · Cited by 16 · see citing works

Polymorphisms in miRNA processing genes and their role in osteosarcoma risk

Bilbao‐Aldaiturriaga, N., Gutiérrez-Camino, Á., Martín‐Guerrero, I., Pombar‐Gomez, M., Zalacaín, M., Patiño‐García, A., López-López, E., & García‐Orad, Á. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25416 · Cited by 15 · see citing works

Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma

Wang, M. J., Zhu, Y., Guo, X. J., & Tian, Z. (2015) · Genetics and Molecular Research · doi:10.4238/2015.september.28.17 · Cited by 14 · see citing works

Activation of HTR2B Suppresses Osteosarcoma Progression through the STAT1‐NLRP3 Inflammasome Pathway and Promotes OASL1+ Macrophage Production to Enhance Antitumor Immunity

Huang, Z. Y., Zhu, J., Hu, J., Wang, X., Ma, X., Xu, E., Zhu, K., & Zhang, C. (2025) · Advanced Science · doi:10.1002/advs.202415276 · Cited by 9 · see citing works

Association between XRCC3 Thr241Met polymorphism and risk of osteosarcoma in a Chinese population

Guo, J., Lv, H., Shi, R. H., & Liu, W. L. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.9.20 · Cited by 8 · see citing works

Whole exome sequencing identified a novel POT1 variant as a candidate pathogenic allele underlying a Li–Fraumeni-like family

Li, Y., Xie, Y., Wang, D., Xu, H., Ye, J., Yin, J. C., Chen, J., Yan, J., Ye, B., & Chen, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.963364 · Cited by 8 · see citing works

Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis‐Related Genes

Yang, M., Su, Y., Xu, K., Zheng, H. J., Cai, Y., Wen, P., Yang, Z., Liu, L., & Xu, P. (2024) · Journal of Immunology Research · doi:10.1155/2024/6595252 · Cited by 6 · see citing works

CD 152 gene polymorphisms and risk of osteosarcoma in Chinese population

Chang, Z., Song, R., Xu, S., Xu, M., & Yu, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-1891-3 · Cited by 5 · see citing works

Investigation on the role of VEGF gene polymorphismsin the risk of osteosarcoma

Yao-nan, Z., Zhao, L., Lin, W., & Shi, L. (2015) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.312.6533 · Cited by 5 · see citing works

HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China

Xiao, W., Zhang, Q., Deng, X. Z., Jiang, L. F., Zhu, D. Y., Pei, J. P., Ge, C. Y., Li, B. J., Wang, C. J., Zhang, J. H., et al. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.06.016 · Cited by 2 · see citing works

The Association of MDM2 c.346G>A Genetic Variant with the Risk of Osteosarcoma in Chinese

Hu, Z., Li, N., Xie, X., & Jiang, R. (2014) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0260 · Cited by 1 · see citing works

Cytotoxic T-lymphocyte Antigen-4 Polymorphisms and Susceptibility to Osteosarcoma

Liu, Y., He, Z., Feng, D., Shi, G., Gao, R., Wu, X., Song, W., & Yuan, W. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1269 · Cited by 61 · see citing works

Cytotoxic T-Lymphocyte Antigen-4 +49G/A Polymorphism Is Associated with Increased Risk of Osteosarcoma

Wang, W., Wang, J., Song, H., Liu, J., Song, B., & Cao, X. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0264 · Cited by 39 · see citing works

Association of genetic polymorphisms with osteosarcoma risk: a meta-analysis.

Bian, Z., He, Q., Wang, X., Li, M., & Zhu, L. (2015) · Europe PMC (PubMed Central) · Cited by 14 · see citing works

Effect of cytotoxic T-lymphocyte antigen-4, TNF-alpha polymorphisms on osteosarcoma: evidences from a meta-analysis.

(2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2013.11.06 · Cited by 16 · see citing works

Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma

Bilbao‐Aldaiturriaga, N., Patiño‐García, A., Martín‐Guerrero, I., & García‐Orad, Á. (2017) · Neoplasma · doi:10.4149/neo_2017_218 · Cited by 15 · see citing works